Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ZLAB | CLUSTER | neutral | 2/10 | Three insiders at Zai Lab (CEO, CLO, CFO) sold a net ~$242K in open-market shares over a 5-day window ending June 30, 20 | Jul 7, 2026 |
| SRRK | CLUSTER | neutral | 2/10 | Two directors at Scholar Rock sold a combined ~$124K in open-market transactions on July 1, 2026, representing ~0.002% o | Jul 7, 2026 |
| ALKS | CLUSTER | neutral | 2/10 | Two Alkermes executives, the EVP/CLO and the EVP R&D/CMO, sold a combined $537K in open-market shares near $52-54, repre | Jul 7, 2026 |
| CSTL | CLUSTER | neutral | 3/10 | CEO Derek Maetzold and COO Kristen Oelschlager sold a combined $351K in open-market shares on July 1, 2026. The CEO's sa | Jul 7, 2026 |
| IBRX | CLUSTER | neutral | 2/10 | Two directors of ImmunityBio sold a combined ~$2.7M in open-market stock this week, following derivative exercises. The | Jul 7, 2026 |
| BOLD | CLUSTER | neutral | 4/10 | Two 10% owners at Boundless Bio (BOLD) traded in opposite directions in the same window: Kevin Tang bought ~$203K worth | Jul 7, 2026 |
| ADPT | CLUSTER | neutral | 4/10 | A cluster of insider selling at Adaptive Biotechnologies has emerged in a two-week window ending July 2, 2026, totaling | Jul 6, 2026 |
| PCVX | CLUSTER | neutral | 2/10 | Two C-suite insiders at Vaxcyte (PCVX) sold shares worth $478K in the past week, but the amount is negligible relative t | Jul 6, 2026 |
| PCVX | CLUSTER | neutral | 2/10 | Insider selling cluster at Vaxcyte (PCVX): CEO Grant Pickering sold $363K and COO Jim Wassil sold $26K in open-market tr | Jul 6, 2026 |
| IONS | CLUSTER | neutral | 3/10 | Multiple IONS insiders including CEO Brett Monia sold shares totaling $7.67M over a 7-day window. However, the total rep | Jul 6, 2026 |
| GLUE | CLUSTER | neutral | 3/10 | Two insiders at Monte Rosa Therapeutics sold a total of $364K in open-market sales over a 7-day window, including the Ch | Jul 6, 2026 |
| IMVT | CLUSTER | neutral | 3/10 | Five Immunovant insiders (CFO, CTO, CLO, COO, and a director) collectively sold ~$2.4M in open-market shares on June 26, | Jul 6, 2026 |
| XERS | CLUSTER | neutral | 4/10 | Two XERS insiders (Kevin McCulloch and Beth Hecht) sold a combined $856K in open-market sales on July 1, 2026, represent | Jul 3, 2026 |
| CTNM | CLUSTER | neutral | 3/10 | Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics exercised and sold shares in a coordinated cluster tota | Jul 3, 2026 |
| RPRX | CLUSTER | neutral | 2/10 | Two EVP-level insiders at Royalty Pharma (RPRX) sold a combined $7.85M in shares over a 7-day window, but this represent | Jul 3, 2026 |
| MAZE | CLUSTER | neutral | 3/10 | CEO Jason Coloma sold ~$1.03M and CSBO Atul Dandekar sold $210K in open-market transactions over a 7-day window, totalin | Jul 3, 2026 |
| KYMR | CLUSTER | bearish | 5/10 | Three Kymera insiders, including CEO Nello Mainolfi, CFO Bruce Jacobs, and a director, sold a combined ~$13.2M in open-m | Jul 3, 2026 |
| QURE | CLUSTER | bearish | 4/10 | Cluster of insider sales at uniQure following two recent $225M and $150M capital raises, with total open-market insider | Jul 3, 2026 |
| SION | CLUSTER | neutral | 4/10 | Two Sionna Therapeutics directors (OrbiMed Advisors LLC and Peter A. Thompson) each sold 115,844 shares at $45.50 on Jun | Jul 3, 2026 |
| HALO | CLUSTER | neutral | 3/10 | Two HALO directors sold a combined $624K in open-market sales over a 3-day window, with the bulk ($548K) from Director K | Jul 3, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP/GC Paul Mahon executed a cluster of open-market sales on July 2, 2026, totaling approximat | Jul 3, 2026 |
| SYRE | CLUSTER | neutral | 3/10 | A small insider selling cluster at Spyre Therapeutics (SYRE) saw CEO Turtle Cameron and CFO Scott Burrows sell a combine | Jul 2, 2026 |
| IMNM | CLUSTER | bearish | 5/10 | Director Isaac Barchas and CMO Robert Lechleider sold a combined $2.93M in open-market sales over a week, with Barchas a | Jul 2, 2026 |
| STTK | CLUSTER | neutral | 3/10 | Two Shattuck Labs executives, the Chief Medical Officer and Chief Technical Officer, sold a combined $376K of stock in a | Jul 2, 2026 |
| KYMR | CLUSTER | bearish | 6/10 | Kymera Therapeutics (KYMR) saw a massive insider selling cluster over the past week, with total open-market sales exceed | Jul 2, 2026 |
| ROIV | CLUSTER | neutral | 5/10 | A cluster of six Roivant insiders, including the President & CIO and the President of Immunovant, sold approximately $13 | Jul 2, 2026 |
| SEPN | CLUSTER | neutral | 2/10 | Two Septerna insiders (SVP Drug Discovery and Chief People Officer) sold a combined $148K in open-market shares after ex | Jul 2, 2026 |
| NRIX | CLUSTER | neutral | 3/10 | Nurix Therapeutics chief legal and scientific officers sold $688K in stock, including a single-day CLO sale of $581K. Th | Jul 2, 2026 |
| CYTK | CLUSTER | neutral | 3/10 | Two C-suite executives (CFO and CCO) sold a combined $1.38M in open-market shares following option exercises, with the C | Jul 2, 2026 |
| ORMP | CLUSTER | neutral | 4/10 | COO/CBO Joshua Hexter and CFO Avraham Gabay collectively sold $942K in open-market shares on July 1, 2026, representing | Jul 2, 2026 |